User menu

Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.

Bibliographic reference Rouwette, Myrthe ; Somers, Klaartje ; Govarts, Cindy ; De Deyn, Peter P ; Hupperts, Raymond ; et. al. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.. In: Journal of Neurochemistry, Vol. 123, no. 4, p. 568-577 (2012)
Permanent URL
  1. Awad Amer, Hemmer Bernhard, Hartung Hans-Peter, Kieseier Bernd, Bennett Jeffrey L., Stuve Olaf, Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis, 10.1016/j.jneuroim.2009.09.002
  2. Becker Kevin G, Mattson David H, Powers James M, Gado Ameer M, Biddison William E, Analysis of a sequenced cDNA library from multiple sclerosis lesions, 10.1016/s0165-5728(97)00045-3
  3. Berger Thomas, Rubner Paul, Schautzer Franz, Egg Robert, Ulmer Hanno, Mayringer Irmgard, Dilitz Erika, Deisenhammer Florian, Reindl Markus, Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event, 10.1056/nejmoa022328
  4. Black J. A., Newcombe J., Waxman S. G., Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5, 10.1093/brain/awq003
  5. Brettschneider Johannes, Tumani Hayrettin, Kiechle Ulrike, Muche Rainer, Richards Gayle, Lehmensiek Vera, Ludolph Albert C., Otto Markus, IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome, 10.1371/journal.pone.0007638
  6. Cavone Leonardo, Chiarugi Alberto, Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?, 10.1016/j.molmed.2011.10.002
  7. Cleutjens, J. Clin. Invest., 118, 2979 (2008)
  8. Evsyukova Irina, Somarelli Jason A., Gregory Simon G., Garcia-Blanco Mariano A., Alternative splicing in multiple sclerosis and other autoimmune diseases, 10.4161/rna.7.4.12301
  9. Fredrikson S, Baig S, Link H, Immunoglobulin producing cells in bone marrow and blood of patients with multiple sclerosis and controls., 10.1136/jnnp.54.5.412
  10. Freedman MS, Laks J, Dotan N, Altstock RT, Dukler A, Sindic CJM, Anti-α-glucose–based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event, 10.1177/1352458508101944
  11. Freedman MS, Metzig C, Kappos L, Polman CH, Edan G, Hartung H-P, Miller DH, Montalban X, Yarden J, Spector L, Fire E, Dotan N, Schwenke S, Lanius V, Sandbrink R, Pohl C, Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis, 10.1177/1352458511432327
  12. GOVARTS C., SOMERS K., HUPPERTS R., STINISSEN P., SOMERS V., Exploring cDNA Phage Display for Autoantibody Profiling in the Serum of Multiple Sclerosis Patients: Optimization of the Selection Procedure, 10.1196/annals.1398.043
  13. Govarts C., Somers K., Hupperts R., Stinissen P., Somers V., Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient, 10.3109/08916930903176513
  14. Hauser Stephen L., Waubant Emmanuelle, Arnold Douglas L., Vollmer Timothy, Antel Jack, Fox Robert J., Bar-Or Amit, Panzara Michael, Sarkar Neena, Agarwal Sunil, Langer-Gould Annette, Smith Craig H., B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis, 10.1056/nejmoa0706383
  15. Hufton Simon E, Moerkerk Peter T, Meulemans Els V, de Bruı̈ne Adriaan, Arends Jan-Willem, Hoogenboom Hennie R, Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands, 10.1016/s0022-1759(99)00139-8
  16. Kuhle Jens, Pohl Christoph, Mehling Matthias, Edan Gilles, Freedman Mark S., Hartung Hans-Peter, Polman Chris H., Miller David H., Montalban Xavier, Barkhof Frederik, Bauer Lars, Dahms Susanne, Lindberg Raija, Kappos Ludwig, Sandbrink Rupert, Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis, 10.1056/nejmoa063602
  17. Lucchinetti Claudia, Br�ck Wolfgang, Parisi Joseph, Scheithauer Bernd, Rodriguez Moses, Lassmann Hans, Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination, 10.1002/1531-8249(200006)47:6<707::aid-ana3>;2-q
  18. Lunemann J. D., Ascherio A., Immune responses to EBNA1: Biomarkers in MS?, 10.1212/wnl.0b013e3181aa2a5f
  19. Mahajan Shahana S., Little Markus M., Vazquez Rafael, Wilson Angus C., Interaction of HCF-1 with a Cellular Nuclear Export Factor, 10.1074/jbc.m205440200
  20. Masjuan J., Alvarez-Cermeno J. C., Garcia-Barragan N., Diaz-Sanchez M., Espino M., Sadaba M. C., Gonzalez-Porque P., San Millan J. M., Villar L. M., Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS, 10.1212/01.wnl.0000198253.35119.83
  21. Mathey Emily K., Derfuss Tobias, Storch Maria K., Williams Kieran R., Hales Kimberly, Woolley David R., Al-Hayani Abdulmonem, Davies Stephen N., Rasband Matthew N., Olsson Tomas, Moldenhauer Anja, Velhin Sviataslau, Hohlfeld Reinhard, Meinl Edgar, Linington Christopher, Neurofascin as a novel target for autoantibody-mediated axonal injury, 10.1084/jem.20071053
  22. McDonald W. Ian, Compston Alistair, Edan Gilles, Goodkin Donald, Hartung Hans-Peter, Lublin Fred D., McFarland Henry F., Paty Donald W., Polman Chris H., Reingold Stephen C., Sandberg-Wollheim Magnhild, Sibley William, Thompson Alan, Van Den Noort Stanley, Weinshenker Brian Y., Wolinsky Jerry S., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, 10.1002/ana.1032
  23. Miller David, Barkhof Frederik, Montalban Xavier, Thompson Alan, Filippi Massimo, Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis, 10.1016/s1474-4422(05)70071-5
  24. Ng Bernard, Yang Fan, Huston David P., Yan Yan, Yang Yu, Xiong Zeyu, Peterson Leif E., Wang Hong, Yang Xiao-Feng, Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes, 10.1016/j.jaci.2004.09.006
  25. Obermeier Birgit, Mentele Reinhard, Malotka Joachim, Kellermann Josef, Kümpfel Tania, Wekerle Hartmut, Lottspeich Friedrich, Hohlfeld Reinhard, Dornmair Klaus, Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis, 10.1038/nm1714
  26. Otto C., Oltmann A., Stein A., Frenzel K., Schroeter J., Habbel P., Gartner B., Hofmann J., Ruprecht K., Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis, 10.1212/wnl.0b013e318215286d
  27. Owens, Mult. Scler., 2, 184 (1996)
  28. Pohl Daniela, Rostasy Kevin, Jacobi Christian, Lange Peter, Nau Roland, Krone Bernd, Hanefeld Folker, Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis, 10.1007/s00415-009-5296-y
  29. Polman Chris H., Reingold Stephen C., Edan Gilles, Filippi Massimo, Hartung Hans-Peter, Kappos Ludwig, Lublin Fred D., Metz Luanne M., McFarland Henry F., O'Connor Paul W., Sandberg-Wollheim Magnhild, Thompson Alan J., Weinshenker Brian G., Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, 10.1002/ana.20703
  30. Rovaris Marco, Confavreux Christian, Furlan Roberto, Kappos Ludwig, Comi Giancarlo, Filippi Massimo, Secondary progressive multiple sclerosis: current knowledge and future challenges, 10.1016/s1474-4422(06)70410-0
  31. Soares M. B., Bonaldo M. F., Jelene P., Su L., Lawton L., Efstratiadis A., Construction and characterization of a normalized cDNA library., 10.1073/pnas.91.20.9228
  32. Somers V. A., Brandwijk R. J., Joosten B., Moerkerk P. T., Arends J.-W., Menheere P., Pieterse W. O., Claessen A., Scheper R. J., Hoogenboom H. R., Hufton S. E., A Panel of Candidate Tumor Antigens in Colorectal Cancer Revealed by the Serological Selection of a Phage Displayed cDNA Expression Library, 10.4049/jimmunol.169.5.2772
  33. Somers V., Govarts C., Hellings N., Hupperts R., Stinissen P., Profiling the autoantibody repertoire by serological antigen selection, 10.1016/j.jaut.2005.09.023
  34. Somers V., Govarts C., Somers K., Hupperts R., Medaer R., Stinissen P., Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates, 10.4049/jimmunol.180.6.3957
  35. Somers Klaartje, Stinissen Piet, Somers Veerle, Optimization of High-throughput Autoantibody Profiling for the Discovery of Novel Antigenic Targets in Rheumatoid Arthritis, 10.1111/j.1749-6632.2009.04654.x
  36. Somers Klaartje, Geusens Piet, Elewaut Dirk, De Keyser Filip, Rummens Jean-Luc, Coenen Marieke, Blom Marlies, Stinissen Piet, Somers Veerle, Novel autoantibody markers for early and seronegative rheumatoid arthritis, 10.1016/j.jaut.2010.10.003
  37. Steinberg Steven J., Dodt Gabriele, Raymond Gerald V., Braverman Nancy E., Moser Ann B., Moser Hugo W., Peroxisome biogenesis disorders, 10.1016/j.bbamcr.2006.09.010
  38. Szmyrka-Kaczmarek, Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis (2011)
  39. Tomassini V., De Giglio L., Reindl M., Russo P., Pestalozza I., Pantano P., Berger T., Pozzilli C., Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS, 10.1177/1352458507077622
  40. Villar Luisa M., Sádaba María C., Roldán Ernesto, Masjuan Jaime, González-Porqué Pedro, Villarrubia Noelia, Espiño Mercedes, García-Trujillo José A., Bootello Alfredo, Álvarez-Cermeño José C., Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS, 10.1172/jci22833
  41. Xiao Qinghuan, Hartzell H. Criss, Yu Kuai, Bestrophins and retinopathies, 10.1007/s00424-010-0821-5
  42. Zéphir H, Lefranc D, Dubucquoi S, de Seze J, Boron L, Prin L, Vermersch P, Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis, 10.1177/1352458508101951
  43. Zhou D., Srivastava R., Nessler S., Grummel V., Sommer N., Bruck W., Hartung H.-P., Stadelmann C., Hemmer B., Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis, 10.1073/pnas.0607242103